Introduction
Autophagy is an intracellular bulk degradation process whereby cytosolic long-lived proteins and organelles are degraded and recycled. 1 Autophagy occurs at basal levels but can be further induced by stress conditions, such as nutrient depletion, 2 and damaging events, such as closed head injury, 3 subarachnoid hemorrhage, 4 or focal cerebral ischemia. 5 Using autophagic degradation of membrane lipids and proteins, cells generate free fatty acids and amino acids, which can be reused to maintain mitochondrial ATP production and protein synthesis, and promote survival. 1 Disruption of autophagic pathways prevents cell survival in diverse organisms. 2 However, in some circumstances, autophagy promotes programmed cell death, 6, 7 indicating that it may have a role in both cell survival and death.
Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia silvia carloni, 1 silvia Girelli, 1 claudia scopa, 1 Giuseppe Buonocore, 2 Mariangela Longini 2 and Walter Balduini 1, Among the genes/proteins that regulate mammalian autophagy, the mammalian target of rapamycin (mTOR) appears to be a key one. mTOR belongs to the phosphatidylinositol kinaserelated protein kinase family and was identified as the cellular target of rapamycin, a lipophilic, macrolid antibiotic with potent antitumor and immunosuppressant effects. Rapamycin inhibits mTOR which negatively regulates autophagy. 8, 9 The inhibition of mTOR induces the expansion step of the pre-autophagosomal membrane, that it necessary for the formation of the autophagic vacuoles. 10 mTOR integrates various signals which regulate cell groWMh and exists in two distinct complexes, mTORC1 and mTORC2, that differ in their subunit composition and sensitivity to rapamycin. 11 mTORC1 is highly sensitive to rapamycin and it is also the principal regulator of autophagy whereas mTORC2 is relatively insensitive to inhibition by acute rapamycin administration and is thought to modulate groWMh factor signaling
We have previously shown that in neonatal rats subjected to hypoxia-ischemia (hi) rapamycin administration increases autophagy, decreases apoptosis and significantly reduces brain damage. After hi, when autophagy is blocked neuronal cells rapidly progress toward necrotic cell death. The present study was undertaken to assess the potential role of activation of autophagic and phosphatidylinositol 3-kinase (Pi3K)/Akt kinase pathways in the neuroprotective effect of rapamycin. Rapamycin administration caused a significant reduction of 70 kDa s6 kinase (p70s6K) phosphorylation and a significant increase of the autophagic proteins Beclin 1 and microtubule-associated protein 1 light chain 3 (Lc3), as of monodansylcadaverine (MDc) labeling in the lesioned side. The phosphorylation of Akt and cAMP response element binding protein (cReB) was increased in neuronal cells, and both p-Akt and p-cReB colocalized with Beclin 1. Wortmannin (WM) administration significantly reduced Akt and cReB phosphorylation as well as the neuroprotective effect of rapamycin but did not affect the phosphorylation of p70s6K, the expression of Beclin 1 and Lc3, and MDc labeling. in contrast, 3-methyladenine (3MA) reduced the increased Beclin 1 expression, the MDc labeling and the neuroprotective effect of rapamycin without affecting Akt phosphorylation. however, both compounds significantly increased necrotic cell death. Taken together, these data indicate that in neonatal hi autophagy can be part of an integrated prosurvival signaling which includes the Pi3K-Akt-mammalian target of rapamycin (mTOR) axis. When the autophagic or the Pi3K-Akt-mTOR pathways are interrupted cells undergo necrotic cell death.
of mTOR and induces autophagy, 8, 9, 31 we assessed the level of phosphorylation of the ribosomal S6 kinase (p70S6K), a mTOR downstream protein, the expression of the two autophagic markers, Beclin 1, a component of the PI3K complex that is required for autophagy, 32 and LC3, a microtubule-associated protein that is lipidated upon activation of autophagy, 33 and the in vivo autophagic vescicle formation and clearance using monodansylcadaverine (MDC). 29 Immunoblot analysis performed 24 h after HI showed a significant reduction of p70S6K phosphorylation in the lesioned side of ischemic animals that was comparable to that observed in rapamycin-treated HI animals. Treatment with rapamycin, however, reduced p70S6K phosphorylation also in the unlesioned side, although the decrease was much lower than that observed in the lesioned side (Fig. 1A) . As expected, both Beclin 1 and lipidated LC3 (LC3 II) levels were significantly increased in the damaged side of rapamycin-treated ischemic animals when compared to that of vehicle treated ischemic animals ( Fig. 1B  and C) . To further assess autophagy activation in this model of neonatal HI, we set up a method for measuring autophagy using in vivo administration of MDC and based on the recently published procedure developed by Perry et al. 29 for measuring cardiac autophagy. No MDC labeling was observed in control animals or in the left unlesioned side of ischemic animals (Fig. 1D) . MDC labeling, instead, was observed in the lesioned side of both vehicle treated (Figs. 1D and 3D and E) and RAP-treated ischemic animals (Figs. 1E and 3D and E). According to Perry et al. 29 MDC labeling colocalized with LC3 II confirming that this reagent can also be used to assess autophagy in the brain (Fig. 1E) .
Because mTOR may represent a crossing point between survival pathways activated by groWMh factors and involving PI3K/Akt, and autophagy, 13 we evaluated the effect of rapamycin treatment on these pathways. We initially tested if the PI3K/Akt pathway was affected by the treatment with rapamycin. The immunohistochemical experiments reported in Figure 2 show that Akt phosphorylation is higher in the lesioned side of HI-rapamycin treated animals ( Fig. 2A, Parts a, d and g ). Furthermore, these experiments show that p-Akt increased in neuronal cells since there was a strong colocalization between pAkt and NeuN ( Fig. 2A,  Parts c, f and i) . Interestingly, pAkt-positive cells also showed increased Beclin 1 expression (Fig. 2B) , indicating that both by phosphorylating the C-terminal hydrophobic motive of some AGC kinases, such as Akt. 12 In Drosophila as well as in human cells mTOR is necessary for Ser473 phosphorylation of Akt, 12 indicating that mTOR complexes may represent a crossing point between autophagy and survival pathways activated by groWMh factors and involving the PI3K-Akt-mTOR axis. 13 Rapamycin has been found to reduce injury in different models of neurodegenerative disorders. [14] [15] [16] In neonatal rats subjected to hypoxia-ischemia (HI) rapamycin administration increases autophagy, reduces the apoptotic signaling and significantly reduces brain damage. 17 On the other hand, when autophagy is blocked neuronal cells rapidly progress toward necrotic cell death 17 indicating that autophagy activation may be part of complex and interrelated signaling pathways that can help cell survival. Rapamycin has been also found to increase Akt phosphorylation, 11, 18, 19 that in neonatal HI was claimed to contribute to the neuroprotective effect of preconditioning, 20 simvastatin 21 as well as hypothermia. 22 The present study was undertaken to assess the potential role of activation of autophagic and Akt/ CREB signaling in the neuroprotective effect of rapamycin in neonatal HI. Using a pharmacological approach in vivo, we show here that blocking either autophagy or Akt signals prevented the neuroprotective effect of rapamycin, indicating that autophagic and survival pathways are strictly interconnected and that their simultaneous activation is mandatory for neuroprotection.
Results
Treatment with rapamycin reduces neonatal brain damage induced by neonatal HI. Ligation of the right common carotid artery followed by 2.5 h hypoxia in neonatal pup rats induced a severe damage in the side of the brain ipsilateral to the occluded carotid ( Table 1) . Rapamycin administration 30 minutes before artery ligation significantly reduced brain injury. As compared to the ischemic group, the injury in rapamycin-treated animals was 42, 60 and 56% lower than that of vehicle-treated ischemic animals, for the whole hemisphere, the cerebral cortex and the hippocampus, respectively.
Treatment with rapamycin activates autophagic as well as survival signaling. Because rapamycin is a well-known inhibitor 
2D).
Note that WM administration did not affect the phosphorylation of p70S6K as well as the expression of Beclin 1 and LC3 II (Fig. 3A-C) . Furthermore, treatment with both WM or the Akt inhibitor IV, a compound that inhibits Akt phosphorylation/activation downstream of PI3K, 34 did not affect the increased MDC labeling observed after RAP treatment ( Fig. 3D and E) . We next evaluated the relevance of activation of autophagy in the neuroprotection induced by rapamycin. To this end we treated pup rats with 3-methyladenine (3MA) that blocks the formation of autophagosomes. 35 Treatment with 3MA reduced the increased Beclin 1 expression observed in HI animals ( Fig. 4A ) without affecting Akt phosphorylation survival and autophagic pathways are activated in the same cells. The increased expression of pAkt in HI-rapamycin treated animals was also confirmed by immunoblot experiments (Fig. 2C) . It should be noted that treatment with rapamycin significantly increases Akt phosphorylation both in the ipsilateral side and in the controlateral side to the occluded carotid.
To assess the relevance of the increased PI3K/Akt pathway activation in the protective effect of rapamycin, pup rats were treated with the PI3K inhibitor wortmannin (WM), 10 min after the administration of rapamycin. WM administration significantly reduced the increased Akt phosphorylation ( to stain necrotic cells, 26 was significantly increased in rapamycin-treated HI animals injected with both 3MA and WM. Consistent with this finding is the observation that rapamycin-treated HI animals injected with both 3MA and WM, as compared to RAP-treated ischemic animals, exhibit larger areas of necrosis in the cortex with cells showing large pyknotic nuclei (Fig. 5B) .
Treatment with rapamycin increases cAMP response element binding protein (CREB) activation. Because it has been previously reported a link between Akt and the transcription factor CREB, 36, 37 which might provide potent survival signals during ischemia, [38] [39] [40] [41] we tested if this survival signaling could also be affected by rapamycin. As shown in Figure 6A , p-CREB colocalized with p-Akt, indicating they are both expressed in the same cells after treatment with rapamycin. CREB was diffusely expressed in the cerebral cortex of ischemic and rapamycin-treated ischemic animals (Fig. 6B, Parts d-f and i-m) and a similar expression of the protein was observed in (Fig. 4B) . 3MA also reduced the increased Beclin 1 expression (Fig. 4C) and MDC labeling ( Fig. 3D and E) observed in rapamycin-treated HI animals as well as the neuroprotective effect of rapamycin (Fig. 4E) without affecting Akt phosphorylation (Fig. 4D) . As shown in Figure 5A , 24 h after HI the number of cells positive to PI, a fluorescent dye utilized in vivo w). Treatment with WM reduced the increased p-CREB expression observed in HI-rapamycin animals (Fig. 6C, Parts s and x) ; treatment with 3MA, conversely, did not affect CREB phosphorylation (Fig. 6C, Parts t and y) . As the antibody that we used the different experimental conditions (Fig. 6E) . Phospho-CREB expression, conversely, was reduced in the ipsilateral side of ischemic animals and appeared markedly increased in the same side of animals treated with rapamycin (Fig. 6C , Parts r and We also show that rapamycin administration increases the level of phosphorylation of Akt and CREB, two well-known prosurvival factors implicated in cell survival after HI in neonatal rats. 20, 21, 47 The overactivation of these factors occurs in neuronal cells and is interconnected, since after rapamycin administration pAkt and p-CREB were overexpressed in the same cells and WM, a PI3K inhibitor, blocked both Akt and CREB phosphorylation. WM also blocked the neuroprotective effect of rapamycin and, interestingly, its effect occurred without affecting the activation of autophagy induced by rapamycin (Figs. 2 and 3) . 3MA administration also prevented the neuroprotective effect of rapamycin but, in contrast, it blocked autophagy without affecting Akt and CREB phosphorylation (Figs. 4 and 6) . Thus, all together these results indicate that either activation of autophagy or PI3K/Akt signals is mandatory for neuroprotection: blocking one of these pathways speeds up the transition of neurons towards necrotic cell death (Fig. 5) .
mTOR, which is the main target of rapamycin in mammalian cells, occurs in two distinct protein complexes: one complex containing mTOR, GβL and raptor (mTORC1), which is rapamycin-sensitive, and another complex containing mTOR, GβL and rictor (mTORC2), which is insensitive to acute rapamycin treatment, although a prolonged treatment can also interfere with this complex.
12 mTORC1 regulates numerous cellular processes such as protein translation, autophagy and microtubule dynamics. 48, 49 Regulation of protein translation by mTORC1 involves two independent, cell-specific pathways: activation of p70S6K and suppression of the elongation factor 4E-BP-1 (4E binding protein 1). [50] [51] [52] mTORC2, on the other hand, regulates actin cytoskeleton organization, but it is also an important factor which regulates Akt activity.
12,53-55 Indeed, mTORC2 is required for Ser473 phosphorylation of Akt in Drosophila cells and in different human cancer cell lines, 12 but also in mice, where mTORC2 is a necessary component of the Akt-FOXO and PKCalpha pathways. 56 In keeping with the effect of mTOR on Akt, we report here that administration of rapamycin resulted in inhibition of mTOR and increased neuroal Akt phosphorylation at Ser473. The increased Akt phosphorylation was not due to reduced PTEN activity, since rapamycin did not modify PTEN expression (data not shown), suggesting that the increased Akt activity was probably directly linked to mTOR inhibition. Our experiments, however, do not discriminate if the increased Akt phosphorylation is mediated by mTORC1 or mTORC2. Previous studies, indeed, have shown that rapamycin can promote Akt phosphorylation in different cell types through inhibition of a negative feedback loop involving mTORC 1-S6 kinase-mediated phosphorylation and degradation to detect p-CREB did not work in western blot experiments, we performed a quantitative analysis of our immunocytochemical experiments. This analysis confirmed the increased p-CREB expression in the injured side of rapamycin-treated ischemic animals and the inhibitory effect of WM (Fig. 6D) .
Discussion
In a previous study we showed that autophagy, a cellular process that causes degradation of long-lived proteins and recycling of cellular components to ensure survival during starvation, was activated after hypoxia-ischemia as a component of survival mechanisms. 17 We showed that rapamycin, a lipophilic macrolide antibiotic that induces autophagy by inactivating mTOR 8 delayed the progression of neuronal cells towards death, whereas if autophagy was blocked cells rapidly underwent to necrotic death. 17 Here we studied in more detail the mechanism(s) of the neuroprotective effect of rapamycin. We found that both autophagic and prosurvival signals must be activated to get neuroprotection. Rapamycin increased the expression of Beclin 1, a component of the PI3K complex that is required for autophagy 32 and used as a marker of this cellular process, 3, 5, 17, 42 and the expression of LC3, a microtubule-associated protein that is lipidated upon activation of autophagy by an ubiquitin-like system involving Apg7 and Apg3. 33, 43 Autophagy activation was also confirmed using MDC labeling. MDC is a compound that is known to label acidic endosomes, lysosomes and autophagosome. 44, 45 We found, according with Perry et al. 29 that when administered IP to neonatal rats 1 h before sacrifice, MDC labels cells only in injured side and strongly colocalizes with LC3 II (Fig. 1) . This finding indicates that MDC can also detect brain autophagy in vivo. 46 This conclusion is further supported by the finding that RAP, which increases Beclin 1 and LC3, two proteins that have been used as markers of autophagy in different animal models of brain injury 5,14,17 also increases MDC labeling (Figs. 1 and 3) . Furthermore, blocking autophagy with 3MA, completely blocks MDC labeling (Fig. 3) . It is not clear, however, if rapamycin increases autophagy with a mechanism related to mTOR inhibition since the levels of p70S6K phosphorylation were almost completely depleted after HI and apparently rapamycin did not further reduce its phosphorylation (Fig. 1A) . A reduction of p70S6K phosphorylation was also observed in the contralateral side of the brain of Rap-treated HI but not in HI rats indicating that the drug, indeed, inhibits the phosphorylation of the protein. The likelihood that rapamycin in this model of HI also increases autophagy via a mTORindependent mechanism needs to be investigated. § p < 0.001, One-way ANOVA followed by Newman-Keuls Multiple comparison Test. (e) infarct volume measured in 14-daysold rats subjected to hi on PN7 and treated with vehicle (hi), rapamycin (hi + RAP), or rapamycin plus 3-methyladenine (hi + RAP + 3MA). Results are expressed as percentage of ipsilateral damage calculated from bilateral regional volumes using the formula: 100(L-R)/L, where L is the volume of the contralateral region and R the volume of the ipsilateral region (N = 10/group). R, right side, ipsilateral to the occluded carotid artery; L, left side, contralateral. *p < 0.05, **p < 0.01, § p < 0.001, One-way ANOVA followed by Newman-Keuls Multiple comparison Test. scale bar, 50 mm.
of insulin receptor substrates. 11, 18, 19, 57 An alternative and more interesting hypothesis, however, is that activation of Akt may occur as a consequence of mTORC2 activation. Indeed, it has been suggested that there is a certain level of competition for mTOR between mTORC1 and mTORC2 and the inhibition of mTORC1 activity by rapamycin may result in increased mTORC2 assembly and activity which may in turn increase the phosphorylation of Akt at Ser473. According to this hypothesis, the relative amount of mTOR sequestered in each of these complexes may balance the level of autophagy and Akt activation. Experiments are in progress to evaluate this hypothesis.
An important finding of the present study is also the observation that either blocking prosurvival signals (i.e., Akt and CREB) or blocking autophagy dramatically increases necrotic cell death, indicating that autophagy and Akt/CREB signals are strictly interconnected. The finding that blocking Akt/CREB signals has deleterious effects in neuronal survival is in line with the numerous evidences that Akt is the major player implicated in cell survival downstream of groWMh factors, oncogenes and stress. 57 In contrast, the finding that blocking autophagy induces necrotic cell death without affecting the increased prosurvival signaling induced by rapamycin is intriguing. It is likely that autophagy can be part of an integrated prosurvival signaling which includes the PI3K-Akt-mTOR axis. When the autophagic or the PI3K-Akt-mTOR pathways are interrupted, cells can undergo to necrotic cell death, as suggested by the increased PI labeling observed in rapamycin-treated ischemic animals after WM or 3MA control for protein gel loading. Blots were analyzed using the NIH-Image software. Data were normalized to Akt or β-actin and expressed as OD integration.
Immunohistochemistry. Pups were deeply anesthetized and perfusion-fixed with 4% paraformaldehyde in 0.1 mol/L PBS. Brains were rapidly removed on ice and processed for antigen retrieval by immersing overnight in 10 mmol/L sodium citrate buffer (pH 6.0, 4°C) and boiling in the same buffer for 3 min. 28 After boiling brains were cryoprotected with 30% sucrose/PBS (72 h, 4°C). Brain sections (thickness 20 mm) were incubated with 1.5% normal blocking serum for 1 h at room temperature, and then overnight at 4°C with anti-CREB or anti-p-CREB ( In some experiments, CREB and p-CREB immunoreactivities were detected with a biotinylated goat anti-rabbit antibody (1:200) and visualized using avidin-biotin peroxidase solution (Elite ABC kit, Vectastain Vector, PK6101). Peroxidase activity was evidenced by 0.05% 3,3'-diaminobenzidine tetrahydrochloride (DAB) and 0.03% H 2 O 2 at the appropriate stage. The specificity of the reactions was evaluated in some slices by omitting the primary antibody from the incubation medium.
Detection of autophagosomes by MDC labeling. One hour before sacrifice, monodancylcadaverine (MDC, 1.5 mg/kg i.p., Sigma, 30432) was injected to additional groups of sham operated (ctrl), ischemic (HI), or ischemic animals treated with (N = 5/group) rapamycin (HI + RAP), wortmannin (HI + WM), 3-methyladenine (HI + 3MA), RAP plus WM (HI + RAP + WM), RAP plus 3MA (HI + RAP + 3MA) or RAP plus the Akt inhibitor IV (HI + RAP + inIV) to label acidic endosomes, lysosomes, and autophagosomes according to Perry et al. 29 After sacrifice, the brains were removed and immediately frozen. To evaluate autophagy, coronal sections of the brain of each animal were cut and MDC staining was evaluated using 365/525 mm excitation/emission filter. Some sections were processed for LC3 immunohistochemical analysis using Texas Red anti-rabbit IgG (1:200; Santa Cruz Biotechnology, sc-3842) to assess immunoreactivity of LC3 as red fluorescence. administration (Fig. 5) . Interestingly, a recent paper has shown that in three different in vitro models of insulin-induced necrotic cell death, activation of the PI3K-Akt-mTOR signaling can promote necrotic cell death via suppression of autophagy. 58 In conclusion, our findings indicate that rapamycin provides neuroprotection against neonatal brain ischemia and this effect is mediated by the concomitant activation of autophagy, the PI3K/ Akt-mTOR axis, and CREB. Further studies are necessary to clarify the connections bridging these pathways in neuroprotection.
Materials and Methods
Cerebral hypoxia-ischemia (HI). All surgical and experimental procedures were carried out in accordance with the Italian regulations for the care and use of laboratory animals, and were approved by the Animal Care Committee of the University of Urbino "Carlo Bo." On postnatal day 7 (PN7), Sprague-Dawley pup rats (Charles River) were anesthetized with 5% isoflurane in N 2 O/O 2 (70/30%) mixture and subjected to ligation of the right common carotid artery followed by 2.5 h hypoxia (92% nitrogen and 8% oxygen) as previously described.
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Drug administration. The pups were anesthetized and placed in a stereotaxic frame. Intracerebroventricular injections were made into the right lateral ventricle using a 5 mL Hamilton syringe. Rapamycin (RAP, 0.5 ng in 0.5 ml 0.1% DMSO; Alexis Biochemicals, 380-004-M001) or the corresponding volume of vehicle were injected 30 minutes before HI; 24 wortmannin (WM, 1 mg in 1 mL 2% DMSO; Sigma, W1628), 3-Methyladenine (3-MA, 5 mL, 10 mM, Sigma, M9281), Akt inhibitor IV (inIV, 1 mg in 1 mL 2% DMSO; Calbiochem, 124011) or the corresponding volume of vehicle were injected 20 minutes before HI. 24, 25 Propidium iodide (PI, half microliter, 1 mg/mL in distilled water; Sigma, P4170) was injected into the right lateral ventricle and 20 minutes after injection animals were sacrificed and perfusionfixed with 4% paraformaldehyde in 0.1 mol/L PBS.
26
Western blot analysis. Samples (50 mg protein; Bradford dyebinding procedure, BioRad Laboratories) were separated onto SDS-polyacrylamide gels as previously described, 27 and probed with the following primary antibodies: anti-p-Akt (1:1,000, polyclonal; Cell Signaling Technology, #9271), anti-Akt (1:1,000, polyclonal; Santa Cruz Biotechnology, #9272), anti-Beclin 1 (1:500, monoclonal; BD Transduction Laboratories, 612113), anti-LC3 (1:1,000, polyclonal; Cell Signaling Technology, #2775), anti-p-p70S6K (1:1,000, polyclonal; Cell Signaling Technology, #9205). Monoclonal antibodies against β-actin (1:4,000, Santa Cruz Biotechnology, sc-8432) was used as a were estimated by summing areas and multiplying by the distance between sections (40 mm).
Data analysis. The relative intensities of the bands detected by western blot were analyzed using the NIH Image 1.62 software. Statistical analyses were performed by one-way ANOVA using Prism Computer program (GraphPad Softwere Inc.,). Percent reduction in whole hemisphere or in the selected brain regions was calculated by using the formula: 100* (left side volume-right side volume)/left side volume, and statistical analysis was performed by Mann-Whitney test. The Newman-Keuls multiple comparison test was used to determine differences between single treatment groups. Programme of the European Commission (LSHM-CT-2006-036534).
Cell counting. Cell counting was conducted in the cerebral cortex on 20X microscopic images using a BX-51 Olympus microscope. Positive cells were counted using the NIH-Image software in three separate fields of the cerebral cortex in slices cut at the level A 3750 of the Koning and Klippel stereotaxic atlas. 30 Five animals for each group were analyzed. Assessment of brain damage. On postnatal day 14, animals were deeply anesthetized and perfusion-fixed with 4% paraformaldehyde in 0.1 mol/L PBS. Brains were rapidly removed on ice, immersion-fixed in 4% paraformaldehyde at 4°C for 4 h and cryoprotected with 8% sucrose/PBS (72 h, 4°C). To evaluate tissue injury, coronal sections (40 mm thick) of the brain of each animal were cut on a cryostat and thaw-mounted onto acid-washed subbed slides (gelatine and chrome alum). Sections were then stained with toluidine blue. A computerized videocamera-based image analysis system (NIH Image software) was used to measure cross-sectional areas from the level of the anterior genu of the corpus callosum to the end of the gyrus dentatus. Measurements, based on the intensity and uniformity of the staining, were performed by an experimenter that was blinded to the conditions of the treatment and included only intact tissue. Regional volumes
